Article

Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results from Phase I of the Texas Coronavirus Antibody REsponse Survey (TX CARES)

2021-08-05

Abstract excerpt

<h4>Introduction</h4> Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and immunity remains uncertain in populations. The state of Texas ranks 2 nd in infection with over 2.71 million cases and has seen a disproportionate rate of death across the state. The TX CARES project was funded by the state of Texas to estimate the prevalence of SARS-CoV-2 antibody status in children and adults. <h4>Ma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e4c4cc6d-eb1c-5489-9da7-5f9a9ec911b3
DOI: 10.1101/2021.08.04.21261613

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results from Phase I of the Texas Coronavirus Antibody REsponse Survey (TX CARES)DOI 10.1101/2021.08.04.21261613Read

Estimated Prevalence of SARS-CoV-2 Antibodies in the Texas Pediatric Population, 2021Semantic proximity Read

SARS-CoV-2 Seroprevalence Studies: A Rapid ReviewSemantic proximity Read

Seroprevalence of SARS-CoV-2 Antibodies Among Rural Healthcare WorkersSemantic proximity Read

First “snap-shot” meta-analysis to estimate the prevalence of serum antibodies to SARS-CoV-2 in humansSemantic proximity Read

Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysisSemantic proximity Read

The prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-upSemantic proximity Read

Estimated SARS-CoV-2 Antibody Seroprevalence and Infection to Case Ratio Trends in 50 States and District of Columbia, United States—October 25, 2020, to February 26, 2022Semantic proximity Read

SARS-CoV-2 antibody prevalence in health care workers: Preliminary report of a single center studySemantic proximity Read

Surveillance genome sequencing reveal multiple SARS-CoV-2 variants circulating in the central Texas, USA with a predominance of Delta variant and review of vaccine breakthrough casesSemantic proximity Read

Prevalence and Incidence of Antibodies Against Sars-Cov-2 Among Primary Healthcare Providers in Belgium During One Year of the Covid-19 Epidemic: Prospective Cohort Study ProtocolSemantic proximity Read

Association of Mass Distribution of Rapid Antigen Tests and SARS-CoV-2 Prevalence: Results from NIH-CDC funded Say Yes! Covid Test program in MichiganSemantic proximity Read

U.S. CDC support to international <i>SARS-CoV-2</i> seroprevalence surveys, May 2020–February 2022Semantic proximity Read